Comprehensive and Clinically Relevant: Covers all key aspects of MAFLD—from historical evolution and pathophysiology to diagnosis, treatment, and long-term management—tailored for everyday clinical practice.
Evidence-Based and Up-to-Date: Integrates the latest guidelines, research, and therapeutic innovations, including emerging pharmacotherapies like resmetirom and GLP-1 agonists.
Diagnostic and Management Tools: Offers detailed guidance on non-invasive diagnostic techniques (e.g., FIB-4, elastography, MRI-PDFF) and practical algorithms for fibrosis staging and patient risk stratification.
Special Population Coverage: Dedicated chapters on MAFLD in children, adolescents, pregnancy, and advanced disease stages including cirrhosis and hepatocellular carcinoma.
Multidisciplinary and Personalized Approach: Highlights the role of endocrinologists, dietitians, primary care providers, and personalized medicine based on genomic profiles.
Public Health Perspective: Includes critical discussion on cost-effective screening strategies, preventive healthcare policy, and future directions with a focus on Indian and global healthcare settings.